Rachel A. Hunter‐Merrill
VA Puget Sound Health Care System · 22 works · 6,559 citations · h-index 8
Top works
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
- Expected population impacts of discontinued prostate‐specific antigen screening
- Is prostate cancer different in black men? Answers from 3 natural history models
- Common variants at 10 genomic loci influence hemoglobin A1C levels via glycemic and nonglycemic pathways (Diabetes (2010) 59, (3229-3239))
- Effect of a Remotely Delivered Self-directed Behavioral Intervention on Body Weight and Physical Health Status Among Adults With Obesity
- Relationships Between Times to Testosterone and Prostate-Specific Antigen Rises During the First Off-Treatment Interval of Intermittent Androgen Deprivation are Prognostic for Castration Resistance in Men With Nonmetastatic Prostate Cancer
- Testing a tailored weight management program for veterans with PTSD: The MOVE! + UP randomized controlled trial
- Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical Trial
- Evaluating the MyPath web-based reproductive decision support tool in VA primary care: Protocol for a pragmatic cluster randomized trial
- Prostate Cancer Characteristics Associated with Response to Pre-Receptor Targeting of the Androgen Axis
- Should Modest Elevations in Prostate-Specific Antigen, International Prostate Symptom Score, or Their Rates of Increase Over Time be Used as Surrogate Measures of Incident Benign Prostatic Hyperplasia?
- Modified Combat Removes Batch Effects from Myeloma Cell GEP–derived Risk Scores and Molecular Subgroup Assignment
- Relationship of time to testosterone (T) and PSA rises during the first “off treatment” interval (1OFF) of intermittent androgen deprivation (IAD) with time to castration resistance (CRPC) and prostate cancer mortality (PCM) in men with biochemical relapse (BR).
- A pilot study of high-dose exisulind in men with biochemical relapse (BCR) of prostate cancer after definitive local therapy treated with intermittent androgen deprivation (IAD).
- System‐Level Predictors of Long‐Acting Reversible Contraception Provision in the Veterans Health Administration
- Intervention Study in Overweight Patients with COPD (INSIGHT COPD): A Pulmonary Trials Cooperative Randomized Clinical Trial
- Time to testosterone (T) and PSA rises during first “off treatment” interval (1OFF-2ON) of intermittent androgen deprivation (IAD) as prognostic for time to castration resistance (CRPC) and prostate cancer mortality (PCM) in men with biochemical relapse (BR).
- Enhanced Weight Management Program for Veterans With Posttraumatic Stress Disorder
- Exploring correlates of 6-month weight loss among black United States veterans entering veterans health administration behavioral weight management care
- Text Message Delivery of a Digital Tool for Reproductive Health Discussions in Primary Care